medical technology

Becton Dickinson surges 5.9% after beating Q2 estimates with $4.71B revenue and raising full-year profit guidance to $12.52-$12.72 EPS.

Stryker raises quarterly dividend 4.8% to $0.88/share, payable July 2026. Q1 net sales reached $6.0 billion, up 2.6% year-over-year.

Smith+Nephew launches two advanced wound care products at EWMA 2026 to address 14.9M chronic wound patients across Europe, reinforcing medtech leadership.

NeurAxis will report Q1 2026 financial results on May 12, 2026, as the neuromodulation company continues commercializing its FDA-cleared IB-Stim technology.

Integra LifeSciences reported Q1 2026 revenues of $391.9M with improved margins, raising full-year EPS guidance while appointing Stuart Essig as new President and CEO.

Senseonics raises $80M through common stock and pre-funded warrant offering to fund Eversense 365 launch and pipeline development, closing May 4, 2026.

Chinese healthcare AI company Yidu Tech projects first annual profit in 11 years at $6-8.2 million for fiscal 2026, driven by strong hospital adoption of AI tools.

Amazon acquires Globalstar for $11.6B to expand satellite internet; Instacart buys Instaleap; QVC files bankruptcy with $5B debt.

Inspira Technologies stock fell 5.96% after-hours despite announcing AME system deployment at U.S. defense customer, raising questions about investor confidence in micro-cap biotech companies.

Enovis sets Q1 2026 earnings call for May 7, backed by 7% full-year 2025 sales growth and strong 10% Reconstructive segment performance.

Stryker schedules virtual annual shareholder meeting for May 6, 2026, declares $0.88 quarterly dividend payable April 30, 2026.

Nuwellis completes acquisition of Rendiatech, adding automated kidney monitoring to its fluid management portfolio for integrated critical care solutions.

IRADIMED Corporation to present MRI-compatible medical device portfolio at prestigious Roth Conference in March 2026, with CEO and CFO meeting investors directly.

Lifeward Ltd. ($LFWD) has regained compliance with Nasdaq's $1.00 minimum bid price requirement, ending delisting risk for the medical technology company.

NexGel acquires regenerative biomaterial portfolio from Celularity, expecting to nearly triple 2026 revenue to $35M and achieve immediate profitability.

$DDD stock jumped 27.30% after reporting strong Q4 revenue growth and significant cost savings, signaling progress toward profitability.

Tactile Medical ($TCMD) appoints veteran healthcare executive Andrea Pearson to board, strengthening governance with 25+ years of industry scaling expertise.

J&J stock hits record highs with 14% monthly returns, outperforming tech due to stable dividends, strong cash flow, and lower volatility amid market uncertainty.

Brain-computer interface market projected to grow from $3.07B to $13.32B by 2035, driven by technological advances and neurological disorder prevalence.

TELA Bio granted 8,550 restricted stock units to three new hires, vesting over four years. The equity compensation aims to attract talent and promote retention.